Inhibition of membrane-bound adrenodoxin-adrenodoxin reductase activity by puromycin and cycloheximide, which antagonize the adrenal steroidogenic action of ACTH.
D000302:Adrenal Cortex / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000325:Adrenodoxin / Q000378:metabolism*; D000818:Animals; D003513:Cycloheximide / Q000494:pharmacology*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D004336:Drug Antagonism; D005287:Ferredoxin-NADP Reductase / Q000378:metabolism*; D007700:Kinetics; D008928:Mitochondria / Q000378:metabolism*; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism*; D009249:NADP; D010084:Oxidation-Reduction; D011691:Puromycin / Q000494:pharmacology*
D000325:Adrenodoxin; D003609:Dactinomycin; D011691:Puromycin; D009249:NADP; D000324:Adrenocorticotropic Hormone; D003577:Cytochrome P-450 Enzyme System; D003513:Cycloheximide; D005287:Ferredoxin-NADP Reductase; D009247:NADH, NADPH Oxidoreductases